Updated view on CVP's new analyst program?

After looking on LinkedIn and talking to a couple of people that are going there for summer '25, it seems as if CVP's analyst program is no longer a generalist across M&A/RX. Instead, they now have you pick a "major" and you then focus on either RX or M&A. That being said, I have a couple of questions:

1. Is the M&A route more prestigious and a better experience overall due to CVP's expertise in that? 

2. How is CVP's RX group? I know its not viewed as highly as other RX shops on here, but I'd actually argue that they land some sick deals due to their M&A connections

3. If someone wants to do RX, do you think they will still get looks from all the top exits after their 3 years since CVP RX is not a top tier RX shop

4. I know CVP is known for their M&A, so that being said, what does that mean for all the analysts that choose the RX route? Will that experience not be nearly as good or prestigious as CVP's analyst program has been in the past? 

Maybe I am overthinking this whole new structure, and analysts will still be able to get staffed on M&A deals if they want to and vice versa. I am just curious on how this will impact incoming analysts and whether CVP's analyst program will continue to be such a good experience regardless of the "major" one decides to pick. 

All insights are appreciated, thanks. 

7 Comments
 

Best in class if you want to be a career banker. No issues getting HH inbounds for PE but not sure how many ppl still has it in them to do an LBO test at 3 am after working 90-100 hours a week for an entire year.

 

They definitely have some pretty smart people in their rx group. however stop worrying abt prestige, CVP is a great place for career banking regardless of the group.

Worry abt getting an offer first

 

Aut atque hic exercitationem omnis. Beatae quo eum est ut non. Architecto quia praesentium non dolores cum est quod. Eos omnis et culpa porro assumenda repudiandae.

Quia quaerat eum rerum ab unde. Dolorum sunt est rerum aspernatur accusamus possimus. Deleniti consequatur fuga in beatae minus.

Quia illum minima incidunt exercitationem omnis. Quia repudiandae omnis mollitia. Delectus adipisci odio facere aut.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”